Skip to main content

letter

. 1996 Aug 3;313(7052):301–302. doi: 10.1136/bmj.313.7052.301b

Monitoring may need to be prolonged in patients given warfarin and amiodarone.

B Tomlinson, R P Young, T Y Chan, J A Critchley, J C Chan

PMCID: PMC2351661 PMID: 8704564

301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cheung B., Lam F. M., Kumana C. R. Insidiously evolving, occult drug interaction involving warfarin and amiodarone. BMJ. 1996 Jan 13;312(7023):107–108. doi: 10.1136/bmj.312.7023.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
Holford N. H. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship. Clin Pharmacokinet. 1986 Nov-Dec;11(6):483–504. doi: 10.2165/00003088-198611060-00005. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES